Nineteen-year-old Áine Rose Hurst tragically died after dismissing a severe headache as a simple hangover following a night out. On 8 March, she returned home complaining of head pain, and her mother advised rest, water, and paracetamol. But over the next few days, the headache worsened until Áine suddenly collapsed on 11 March. She was rushed to Royal Bolton Hospital, where doctors discovered severe brain swelling. Despite medical efforts, she passed away two days later. An inquest later revealed that Áine died from cerebral venous sinus thrombosis — a rare blood clot in the brain — and that her combined oral contraceptive pill, Femodette, was identified as a potential contributing factor. The coroner acknowledged that such complications are recognized but extremely rare, describing her death as the tragic result of an uncommon side effect from appropriately prescribed medication.

Áine had been taking the pill since 2020 and was advised to stop in December 2024 after a routine check-up showed high blood pressure. Though later readings appeared normal, she asked to resume the pill during a GP appointment in January 2025. After discussing alternatives, she chose to return to her previous prescription, a decision her doctor considered reasonable at the time. No warning signs suggested imminent danger. Her death has left her family devastated. They described Áine as vibrant, loving, and full of laughter — the life of every gathering, always leading karaoke or quizzes with joyful enthusiasm. Now, her absence has created an immeasurable void. Her family say life will never be the same without their “beautiful, caring, funny and sensible girl,” whose sudden loss serves as a heartbreaking reminder that rare medical risks, though unlikely, can carry unimaginable consequences.